Q2 adjusted EBITDA is expected to be $33.0M-$40.0M. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot Stocks on TipRanks >> Read More on EVH: EVH Earnings this Week: How Will it Perform? Evolent Health’s Promising Financial Outlook Justifies Buy Rating Evolent Health Nominates Shawn Guertin to Board MCOs’ ‘mixed messages’ creating volatility in value-based care, says Truist Evolent Health price target lowered to $14 from $15 at Truist Disclaimer & DisclosureReport an Issue
